文献速递临床免疫分子诊断临床微生物

超灵敏唾液SARS-CoV-2抗原检测方法

Ultrasensitive assay for saliva-based SARS-CoV-2 antigen detection.
PubMed 文献 · Clin Chem Lab Med · 2022-02-16

本研究开发了一种基于电化学发光(ECL)的超灵敏唾液SARS-CoV-2核衣壳抗原检测方法,分析灵敏度<0.32 pg/mL,相当于4个病毒RNA拷贝/µL。在105例唾液样本中,100%特异性下灵敏度为92%,并在689例独立队列中验证(阳性率3.8%),灵敏度同样为92%。该方法比Abbott Panbio快速检测灵敏度高约700倍,与基于唾液的PCR和鼻咽拭子PCR结果高度一致。

要点

  • ECL免疫法检测唾液N抗原,分析灵敏度<0.32 pg/mL。
  • 两个队列中100%特异性下灵敏度均为92%。
  • 比Abbott Panbio快速检测灵敏度高约700倍。

核心结论

  • 超灵敏唾液抗原检测法具有高灵敏度和特异性,与PCR结果一致,适用于频繁检测。

研究设计与样本

  • 使用新型ECL免疫法测量105例唾液样本的SARS-CoV-2 N抗原浓度,并在689例独立队列中验证(阳性率3.8%)。

主要发现

  • 第一队列中,100%特异性下灵敏度为92%,可识别病毒载量高达35 CT循环的样本。
  • 第二队列中,100%特异性下灵敏度也为92%,与唾液PCR和鼻咽拭子PCR高度一致。
  • 该方法比Abbott Panbio快速检测灵敏度高约700倍。

关键数值与推荐

  • 分析灵敏度<0.32 pg/mL,相当于4个病毒RNA拷贝/µL。
  • 在N抗原浓度阴性(<0.32 pg/mL)和强阳性(>2 pg/mL)样本中与PCR高度一致。

临床怎么用

  • 适用于依从性差或频繁采样的场景,提供高灵敏度的唾液抗原检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Widespread SARS-CoV-2 testing is invaluable for identifying asymptomatic/pre-symptomatic individuals. There remains a technological gap for highly reliable, easy, and quick SARS-CoV-2 diagnostic tests suitable for frequent mass testing. Compared to nasopharyngeal (NP) swab-based tests, saliva-based methods are attractive due to easier and safer sampling. Current saliva-based SARS-CoV-2 rapid antigen tests (RATs) are hindered by limited analytical sensitivity. Here, we report one of the first ultrasensitive, saliva-based SARS-CoV-2 antigen assays with an analytical sensitivity of <0.32 pg/mL, corresponding to four viral RNA copies/µL, which is comparable to that of PCR-based tests. METHODS: Using the novel electrochemiluminescence (ECL)-based immunoassay, we measured the SARS-CoV-2 nucleocapsid (N) antigen concentration in 105 salivas, obtained from non-COVID-19 and COVID-19 patients. We then verified the results with a second, independent cohort of 689 patients (3.8% SARS-CoV-2 positivity rate). We also compared our method with a widely used point-of-care rapid test. RESULTS: In the first cohort, at 100% specificity, the sensitivity was 92%. Our assay correctly identified samples with viral loads up to 35 CT cycles by saliva-based PCR. Paired NP swab-based PCR results were obtained for 86 cases. Our assay showed high concordance with saliva-based and NP swab-based PCR in samples with negative (<0.32 pg/mL) and strongly positive (>2 pg/mL) N antigen concentrations. In the second cohort, at 100% specificity, sensitivity was also 92%. Our assay is about 700-fold more sensitive than the Abbott Panbio Rapid Test. CONCLUSIONS: We demonstrated the ultrasensitivity and specificity assay and its concordance with PCR. This novel assay is especially valuable when compliance to frequent swabbing may be problematic.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Ren A, Sohaei D, Ulndreaj A, et al. Ultrasensitive assay for saliva-based SARS-CoV-2 antigen detection. Clin Chem Lab Med. 2022. PMID: 35170269. doi:10.1515/cclm-2021-1142

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。